These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7739406)

  • 1. Stark II bans 11 "designated health services".
    Mich Med; 1995 Mar; 94(3):26-30. PubMed ID: 7739406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I Stark II regulations provide some flexibility.
    Chase L
    Healthc Financ Manage; 2001 Oct; 55(10):52-9. PubMed ID: 11588868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Stark" reality: self-referral rule holds risk and opportunity.
    Lebowitz PH
    Radiol Manage; 2001; 23(5):34-9. PubMed ID: 11680255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Stark II Rules on interventional pain practices.
    Sarraille WA
    Pain Physician; 2001 Apr; 4(2):196-203. PubMed ID: 16902693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical applications of Stark II to hospital operations.
    Higgins DB; Hayes ML
    Healthc Financ Manage; 1993 Dec; 47(12):76-8, 81, 83-5. PubMed ID: 10145917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare and Medicaid programs; physicians' referrals to health care entities with which they have financial relationships. Health Care Financing Administration (HCFA), HHS. Final rule with comment period.
    Fed Regist; 2001 Jan; 66(3):856-965. PubMed ID: 11503745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare and Medicaid programs; physicians' referrals to health care entities with which they have financial relationships--HCFA. Proposed rule.
    Fed Regist; 1998 Jan; 63(6):1659-728. PubMed ID: 10177062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician refer thyself: is Stark II, phase III the final voyage?
    Manchikanti L; McMahon EB
    Pain Physician; 2007 Nov; 10(6):725-41. PubMed ID: 17987094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finally, HCFA proposes regulations interpreting stark II.
    Katayama AC
    WMJ; 1998 Mar; 97(3):67-73. PubMed ID: 9540454
    [No Abstract]   [Full Text] [Related]  

  • 10. Fraud and abuse. Understanding the Stark II proposed regulations.
    Davis JP
    Healthc Financ Manage; 1998 Apr; 52(4):65-9. PubMed ID: 10178067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfing Stark II: prohibition against self-referrals.
    Swibel HJ; Zaremski MJ
    Physician Exec; 1995 Feb; 21(2):11-5. PubMed ID: 10140213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapting to the Stark II antireferral ban: a practical analysis of the prohibition and exceptions.
    Ronai SE; Peterson NN
    Conn Med; 1995 Mar; 59(3):157-60. PubMed ID: 7729137
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicare and Medicaid programs; physicians' referrals to health care entities with which they have financial relationships: partial delay of effective date. Interim final rule with comment period; partial delay in effective date.
    Centers for Medicare & Medicaid Services (CMS), DHHS
    Fed Regist; 2001 Dec; 66(232):60154-6. PubMed ID: 11778624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Devaluing a specialty: the Centers for Medicare and Medicaid Services proposal to eliminate consultation codes.
    Martinelli LP; McQuillen DP; Scull JA
    Clin Infect Dis; 2009 Oct; 49(7):995-6. PubMed ID: 19719416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stark II enacted as part of the Omnibus Budget Reconciliation Act of 1993.
    Frazier RT; Thallner KA
    Del Med J; 1993 Dec; 65(12):783-5. PubMed ID: 8258374
    [No Abstract]   [Full Text] [Related]  

  • 16. Stark reality.
    Flanagan EM; Thiel DK
    Health Prog; 1990 Apr; 71(3):70-4. PubMed ID: 10106618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stark II and its effect on orthopaedic practice.
    Smith KT
    Orthop Nurs; 1997; 16(1):17-20. PubMed ID: 9110815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stark II: New restrictions on referrals.
    Vaughn TD
    Mo Dent J; 1995; 75(1):13-5. PubMed ID: 9564301
    [No Abstract]   [Full Text] [Related]  

  • 19. Key changes to the Stark II final rule.
    Riley J; Pristave R
    Nephrol News Issues; 2008 Jan; 22(1):42-3, 56. PubMed ID: 18271439
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicare program; physician financial relationships with, and referrals to, health care entities that furnish clinical laboratory services and financial relationship reporting requirements--HCFA. Final rule with comment period.
    Fed Regist; 1995 Aug; 60(156):41914-82. PubMed ID: 10144842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.